1. Australian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel. Issue 10 (October 2014) Authors: Alexander, M.; King, J.; Bajel, A.; Doecke, C.; Fox, P.; Lingaratnam, S.; Mellor, J. D.; Nicholson, L.; Roos, I.; Saunders, T.; Wilkes, J.; Zielinski, R.; Byrne, J.; MacMillan, K.; Mollo, A.; Kirsa, S.; Green, M. Journal: Internal medicine journal Issue: Volume 44:Issue 10(2014) Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014. Issue 12 (December 2014) Authors: Fleming, S.; Yannakou, C. K.; Haeusler, G. M.; Clark, J.; Grigg, A.; Heath, C. H.; Bajel, A.; van Hal, S. J.; Chen, S. C.; Milliken, S. T.; Morrissey, C. O.; Tam, C. S.; Szer, J.; Weinkove, R.; Slavin, M. A. Journal: Internal medicine journal Issue: Volume 44:Issue 12b(2014) Page Start: 1283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient. Issue 1 (20th December 2012) Authors: Osthoff, M.; Chew, E.; Bajel, A.; Kelsey, G.; Panek‐Hudson, Y.; Mason, K.; Szer, J.; Ritchie, D.; Slavin, M. Journal: Transplant infectious disease Issue: Volume 15:Issue 1(2013) Page Start: E14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nephrotic syndrome as a complication of chronic graft‐versus‐host disease after allogeneic haemopoietic stem cell transplantation. Issue 6 (3rd June 2016) Authors: Wong, E.; Lasica, M.; He, S. Z.; Bajel, A.; Roberts, A. W.; Mason, K. D.; Ritchie, D. S.; Szer, J. Journal: Internal medicine journal Issue: Volume 46:Issue 6(2016) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P361: EARLY MEASURABLE RESIDUAL DISEASE ANALYSIS IS ONLY PREDICTIVE OF SURVIVAL OUTCOMES AFTER TWO CYCLES OF TREATMENT IN ADULTS WITH B-LYMPHOBLASTIC LEUKEMIA RECEIVING HYPER-CVAD INDUCTION. (23rd June 2022) Authors: Nedumannil, R.; Ritchie, D.; Bajel, A.; Ng, A. P.; Harrison, S. J.; Westerman, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗